Search

Your search keyword '"Fumio Itoh"' showing total 17 results
Start Over Author "Fumio Itoh" Publisher japan society of hepatology
17 results on '"Fumio Itoh"'

2. Two cases of acute hepatitis with false positive for IgA HEV antibody

Author

Takanobu Kato, Nozomi Morita, Yosuke Satta, Tsunamasa Watanabe, Keigo Suetani, Hiroshi Yasuda, Norie Yamada, Hirofumi Kiyokawa, Chiaki Okuse, Kotaro Matsunaga, Tetsuya Hiraishi, Fumio Itoh, Hiroyasu Nakano, Shinya Ishigooka, Hiroshi Yotsuyanagi, and Michihiro Suzuki

Subjects
Hepatology, biology, business.industry, Immunology, biology.protein, Medicine, Antibody, business, Acute hepatitis
Published
2021

3. The clinical investigation of 153 liver abscesses in the past 20 years

Author

Toshiya Ishii, Kazunari Nakahara, Ryo Morita, Hiroyasu Nakano, Yohei Noguchi, Kensuke Tsuji, Keigo Suetani, Nozomi Morita, Chiaki Okuse, Nobuhiro Hattori, Ryosuke Oumi, Takuya Ehira, Hiroki Ikeda, Yosuke Igarashi, Michihiro Suzuki, Tsunamasa Watanabe, Tetsuya Hiraishi, Nobuyuki Matsumoto, Tatsuya Suzuki, Fumio Itoh, Yosuke Michikawa, Hiroyuki Kunishima, Ryuta Shigefuku, Hideaki Takahashi, and Kotaro Matsunaga

Subjects
03 medical and health sciences, medicine.medical_specialty, 0302 clinical medicine, Hepatology, business.industry, Clinical investigation, General surgery, medicine, 030211 gastroenterology & hepatology, 030212 general & internal medicine, business
Published
2018

4. Nine cases of pyogenic liver abscesses caused by Fusobacterium: Review and literature in Japan

Author

Hiroki Ikeda, Kotaro Matsunaga, Fumio Itoh, Hiroyuki Kunishima, Hiroyuki Yamamoto, Chiaki Okuse, Takuya Ehira, Ryuta Shigefuku, Tsunamasa Watanabe, Nobuhiro Hattori, Michihiro Suzuki, Nobuyuki Matsumoto, and Hiroyasu Nakano

Subjects
0301 basic medicine, medicine.medical_specialty, Hepatology, biology, business.industry, biology.organism_classification, Dermatology, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Fusobacterium, 030220 oncology & carcinogenesis, medicine, business
Published
2018

5. A case of acute hepatitis B occurred secondary to amebic colitis

Author

Keigo Suetani, Hiroyasu Nakano, Michihiro Suzuki, Hideaki Takahashi, Nobuyuki Matsumoto, Nozomi Morita, Toshiya Ishii, Tetsuya Hiraishi, Tsunamasa Watanabe, Tatsuya Suzuki, Chiaki Okuse, Kotaro Matsunaga, Hiroki Ikeda, Yusuke Satta, Shinya Ishigooka, Hiroshi Yotsuyanagi, and Fumio Itoh

Subjects
0301 basic medicine, 03 medical and health sciences, medicine.medical_specialty, Amebic colitis, Hepatology, business.industry, Internal medicine, 030106 microbiology, medicine, Acute hepatitis B, business, Gastroenterology
Published
2017

6. Emergence of the beclabuvir resistance-associated substitution P495L during daclatasvir/asunaprevir/beclabuvir treatment in DAA retreatment case with hepatitis C virus-associated cirrhosis

Author

Keiji Matsui, Hiroki Ikeda, Nobuyuki Matsumoto, Michihiro Suzuki, Chiaki Okuse, Shogo Iwabuchi, Fumio Itoh, Tsubasa Abe, Ryuta Shigefuku, Tomoaki Fuzikawa, Hideaki Takahashi, Mitsuru Nagata, Tsunamasa Watanabe, Nobuhiro Hattori, Hirohito Shimizu, and Kotaro Matsunaga

Subjects
0301 basic medicine, Cirrhosis, Daclatasvir, Hepatology, business.industry, Hepatitis C virus, 030106 microbiology, medicine.disease, medicine.disease_cause, Virology, 03 medical and health sciences, chemistry.chemical_compound, chemistry, medicine, Asunaprevir, business, Beclabuvir, medicine.drug
Published
2017

7. A case of rhabdomyolysis associated with combined administration of daclatasvir and asunaprevir for the treatment of chronic hepatitis C

Author

Hiroshi Yotsuyanagi, Toshiya Ishii, Hiroki Ikeda, Satoko Nakatsu, Tetsuya Hiraishi, Michihiro Suzuki, Shinya Ishigohoka, Keigo Suetani, Nobuyuki Matsumoto, Kensuke Tsuji, Fumio Itoh, Chiaki Okuse, Nozomi Sato, Hideaki Takahashi, Ryosuke Ohmi, Kotaro Matsunaga, and Tsunamasa Watanabe

Subjects
medicine.medical_specialty, Daclatasvir, Hepatology, business.industry, medicine.disease, Gastroenterology, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, chemistry, Chronic hepatitis, Internal medicine, medicine, Asunaprevir, 030211 gastroenterology & hepatology, 030212 general & internal medicine, business, Rhabdomyolysis, medicine.drug
Published
2016

8. Effect of switching of previous nucleos(t)ide analogues to Tenofovir on Hepatitis B surface antigen levels

Author

Nozomi Morita, Hiroki Ikeda, Toshiya Ishii, Tsunamasa Watanabe, Fumio Itoh, Chiaki Okuse, Keigo Suetani, Hideaki Takahashi, Tetsuya Hiraishi, Nobuyuki Matsumoto, Kotaro Matsunaga, Shinya Ishigooka, Hiroshi Yotsuyanagi, and Michihiro Suzuki

Subjects
03 medical and health sciences, 0302 clinical medicine, Hepatology, Tenofovir, business.industry, Medicine, 030211 gastroenterology & hepatology, 030212 general & internal medicine, business, Hepatitis b surface antigen, Virology, medicine.drug
Published
2017

9. Pegylated interferon and ribavirin combination therapy for chronic hepatitis C associated with thyroid dysfunction

Author

Hiroki Ikeda, Michihiro Suzuki, Kazuhiko Koike, Nobuhiro Hattori, Yohei Noguchi, Nobuyuki Matsumoto, Kotaro Matsunaga, Junko Shima, Miki Okano, Chiaki Okuse, Fumio Itoh, Moriaki Hatsugai, Akira Sato, Hiroshi Yotsuyanagi, Kazunari Nakahara, Toshiya Ishii, Ryuta Shigefuku, Hideaki Takahashi, and Yasunobu Fukuda

Subjects
medicine.medical_specialty, Hepatology, Combination therapy, business.industry, Ribavirin, Gastroenterology, chemistry.chemical_compound, chemistry, Chronic hepatitis, Pegylated interferon, Thyroid dysfunction, Internal medicine, medicine, business, medicine.drug
Published
2013

10. Evaluation of usefulness of hepatitis B vaccination at St. Marianna University School of Medicine Hospital and related facilities

Author

Takahide Matsuda, Michihiro Suzuki, Kiyomi Yasuda, Hiroshi Yotsuyanagi, Junko Aono, Kazuhiko Koike, Fumio Itoh, Masatoshi Hara, Chiaki Okuse, and Norie Yamada

Subjects
medicine.medical_specialty, Hepatology, business.industry, Hepatitis b vaccination, Internal medicine, medicine, business
Abstract

2004年から2008年までにB型肝炎（HB）ワクチン接種が完遂された601名を対象とし，HBワクチンの有用性を検討した．全体でのHBs抗体陽転率は92.2％であった．年齢層別の検討では，20～29歳の群でHBs抗体陽転率が86.0％と他の群に比較し低値であり，19歳以下の群と有意差を認めたが（P

Published
2011

12. Frequency and risk factors for retinopathy associated with pegylated interferon α2b and ribavirin combination therapy in patients with chronic hepatitis C

Author

Nobuyuki Matsumoto, Michihiro Suzuki, Hideaki Takahashi, Shiro Iino, Minoru Kobayashi, Hiroshi Yotsuyanagi, Kotarou Matsunaga, Kazuhiko Koike, Masaru Okamoto, Yoshihiko Nagase, Hiroki Ikeda, Fumio Itoh, Norie Yamada, Chiaki Okuse, and Yoshiki Katakura

Subjects
medicine.medical_specialty, Hepatology, Combination therapy, business.industry, Ribavirin, medicine.disease, Gastroenterology, chemistry.chemical_compound, Chronic hepatitis, chemistry, Pegylated interferon, Internal medicine, medicine, In patient, business, medicine.drug, Retinopathy
Published
2008

13. Successful treatment of hemobilia associated with biliary tract infiltration of hepatocellular carcinoma by transcatheter arterial embolization: a case report

Author

Chiaki Okuse, Gaku Igarashi, Toshiya Ishii, Koutarou Matsunaga, Fumio Itoh, Moriaki Hatsugai, Michihiro Suzuki, and Yoshiki Katakura

Subjects
medicine.medical_specialty, Hepatology, Biliary tract, business.industry, Hepatocellular carcinoma, Arterial Embolization, medicine, Radiology, medicine.disease, business, Infiltration (medical)
Abstract

58歳男性．55歳時に肝細胞癌と診断され，血管内治療や局所治療を繰り返し施行するも制御困難で，57歳時に肝動注化学療法（HAIC）が導入された．HAICにより一時的な抗腫瘍効果が得られていたが，6クール目のHAIC目的に入院した際，タール便を認め，上部消化管内視鏡検査にてVater乳頭開口部よりの血液の流出を認めた．腹部造影CTで右肝管内への腫瘍浸潤を認めたことから胆道出血が疑われた．腹部血管造影では右肝管に一致した部位に腫瘍濃染像を認め，肝動脈塞栓術を施行し，止血を得た．以後，HAICを2クール施行したが7カ月後に肝不全で死亡した．本邦既報告例41例を含めた検討では，胆道出血をきたした肝細胞癌の予後は不良であるが，肝動脈塞栓術は止血に有用であり，止血を得ることで継続した抗癌治療への移行も可能であると考えられた．

Published
2007

14. A resected case with tract seeding of HCC after percutaneous local treatment

Author

Yasuhito Takahashi, Hitonobu Moriya, Koutaro Matsunaga, Jyo Sakurai, Hiroki Ikeda, Minoru Kobayashi, Hideaki Takahashi, Toshiya Ishii, Hiroshi Yotsuyanagi, Fumio Itoh, Junki Koike, and Michihiro Suzuki

Subjects
medicine.medical_specialty, Percutaneous, Hepatology, business.industry, Tract Seeding, medicine, Radiology, business
Abstract

55歳, 男性. B型肝硬変で経過観察中, 平成15年1月にS5, S6に肝細胞癌を認め肝動脈塞栓術に引き続きラジオ波焼灼療法 (以下RFA), エタノール注入療法 (以下PEIT) の局所治療を行った. 3カ月後, CTにてPEITの穿刺ルートに当たる肝表面と腹壁の間に結節病変の出現を認め, 入院となった. 結節病変はCT, MRI, 造影超音波にて造影効果が認められ, 胃十二指腸動脈造影にて濃染を呈し播種性結節と診断した. 12月2日, 大網部分切除を行い, 同時に肝内再発病変に対し肝部分切除を施行した. 肝内の再発病変は組織学的には中分化型の肝細胞癌であり, 大網内の結節からも同様の所見が得られた. 術後15カ月後の現在まで, 再発, 転移は認めない. 肝癌の局所治療の際は, 播種を意識した治療前の穿刺ルートの画像確認が必要であり, 被膜下病変には, 治療後早期からの穿刺経路・近隣臓器の画像観察が重要であると考えられた. また, 播種病変に対する治療は可能な限り切除を行うことが長期予後の改善につながるものと思われた.

Published
2005

15. [Untitled]

Author

Itaru OZEKI, Shigeru SASAKI, Taiga TAKAHASHI, Masako TAGA, Kimiko HASEGAWA, Hideyasu TAKAGI, Shina HORIUCHI, Susumu NISHIMURA, Yasuyo ADACHI, Hiroyuki KANETO, Fumio ITOH, Kazumitsu KOITO, and Kohzoh IMAI

Subjects
Hepatology
Published
2002

16. [Untitled]

Author

Itaru OZEKI, Shigeru SASAKI, TAIGA Takahashi, Norikazu IWATA, Hiroyuki KANETO, Satoshi MOTOYA, Fumio ITOH, Tadashi KATSURAMAKI, Kazumitsu KOITO, and Kohzoh IMAI

Subjects
Hepatology
Published
2001

17. Efficacy of 60 weeks treatment of pegylated interferon plus ribavirin in patients whose HCV RNA tuned negative by real-time PCR assay at 12 weeks

Author

Hideaki Takahashi, Masaru Okamoto, Yoshihiko Nagase, Hiroki Ikeda, Fumio Itoh, Norie Yamada, Hiroshi Yotsuyanagi, Kotaro Matsunaga, Minoru Kobayashi, Yasunobu Fukuda, Chiaki Okuse, Michihiro Suzuki, Kiyomi Yasuda, and Nobuyuki Matsumoto

Subjects
medicine.medical_specialty, Cirrhosis, Hepatology, business.industry, Ribavirin, Guideline, medicine.disease, Gastroenterology, Surgery, chemistry.chemical_compound, Real-time polymerase chain reaction, chemistry, Pegylated interferon, Internal medicine, Genotype, medicine, Viral hepatitis, business, Viral load, medicine.drug
Abstract

Pegylated interferon combined with ribavirin treatment for 48 weeks is commonly used for chronic hepatitis C patients with genotype 1 and high viral load. Additionally, the 2010 guideline by the Study Group for the Standardization of Treatment of Viral Hepatitis Including Cirrhosis, under the auspice of the Ministry of Health Labor and Welfare of Japan newly recommends 72 weeks treatment for elder female or advanced stage patients, whose HCV RNA turned negative at between 9 and 36 weeks by real-time PCR. In this study, we investigated the efficacy of 60 weeks treatment in patients, whose HCV RNA turned negative at 12 weeks. SVR was achieved in 29 out of 30 cases. Among those cases, 8 females were over 50 years old, and 6 cases were advanced stage. Sixty weeks treatment is considered satisfactory for patients whose HCV RNA turned negative at 12 weeks.

Published
2010

Catalog

Books, media, physical & digital resources
See catalog results